Literature DB >> 21615170

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.

Carlee E Ashley1, Eric C Carnes, Genevieve K Phillips, Paul N Durfee, Mekensey D Buley, Christopher A Lino, David P Padilla, Brandy Phillips, Mark B Carter, Cheryl L Willman, C Jeffrey Brinker, Jerri do Carmo Caldeira, Bryce Chackerian, Walker Wharton, David S Peabody.   

Abstract

Virus-like particles (VLPs) of bacteriophage MS2 possess numerous features that make them well-suited for use in targeted delivery of therapeutic and imaging agents. MS2 VLPs can be rapidly produced in large quantities using in vivo or in vitro synthesis techniques. Their capsids can be modified in precise locations via genetic insertion or chemical conjugation, facilitating the multivalent display of targeting ligands. MS2 VLPs also self-assemble in the presence of nucleic acids to specifically encapsidate siRNA and RNA-modified cargos. Here we report the use of MS2 VLPs to selectively deliver nanoparticles, chemotherapeutic drugs, siRNA cocktails, and protein toxins to human hepatocellular carcinoma (HCC). MS2 VLPs modified with a peptide (SP94) that binds HCC exhibit a 10(4)-fold higher avidity for HCC than for hepatocytes, endothelial cells, monocytes, or lymphocytes and can deliver high concentrations of encapsidated cargo to the cytosol of HCC cells. SP94-targeted VLPs loaded with doxorubicin, cisplatin, and 5-fluorouracil selectively kill the HCC cell line, Hep3B, at drug concentrations <1 nM, while SP94-targeted VLPs that encapsidate a siRNA cocktail, which silences expression of cyclin family members, induce growth arrest and apoptosis of Hep3B at siRNA concentrations <150 pM. Impressively, MS2 VLPs, when loaded with ricin toxin A-chain (RTA) and modified to codisplay the SP94 targeting peptide and a histidine-rich fusogenic peptide (H5WYG) that promotes endosomal escape, kill virtually the entire population of Hep3B cells at an RTA concentration of 100 fM without affecting the viability of control cells. Our results demonstrate that MS2 VLPs, because of their tolerance of multivalent peptide display and their ability to specifically encapsidate a variety of chemically disparate cargos, induce selective cytotoxicity of cancer in vitro and represent a significant improvement in the characteristics of VLP-based delivery systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615170      PMCID: PMC3144304          DOI: 10.1021/nn201397z

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  39 in total

1.  Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.

Authors:  Ernest W Kovacs; Jacob M Hooker; Dante W Romanini; Patrick G Holder; Katherine E Berry; Matthew B Francis
Journal:  Bioconjug Chem       Date:  2007-06-30       Impact factor: 4.774

2.  Oxidative coupling of peptides to a virus capsid containing unnatural amino acids.

Authors:  Zachary M Carrico; Dante W Romanini; Ryan A Mehl; Matthew B Francis
Journal:  Chem Commun (Camb)       Date:  2008-01-29       Impact factor: 6.222

3.  Nanogeometry: beyond drug delivery.

Authors:  Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03       Impact factor: 39.213

4.  A coat for all sequences.

Authors:  O C Uhlenbeck
Journal:  Nat Struct Biol       Date:  1998-03

5.  Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells.

Authors:  Giuseppe Destito; Robert Yeh; Chris S Rae; M G Finn; Marianne Manchester
Journal:  Chem Biol       Date:  2007-10

6.  Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.

Authors:  J O Lee; K W Lee; D Y Oh; J H Kim; S A Im; T Y Kim; Y J Bang
Journal:  Ann Oncol       Date:  2009-06-05       Impact factor: 32.976

Review 7.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

8.  The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles.

Authors:  Nicole M Moore; Clayton L Sheppard; Tiffany R Barbour; Shelly E Sakiyama-Elbert
Journal:  J Gene Med       Date:  2008-10       Impact factor: 4.565

9.  Interior surface modification of bacteriophage MS2.

Authors:  Jacob M Hooker; Ernest W Kovacs; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

10.  Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.

Authors:  Pratik Singh; Giuseppe Destito; Anette Schneemann; Marianne Manchester
Journal:  J Nanobiotechnology       Date:  2006-02-13       Impact factor: 10.435

View more
  79 in total

1.  Deletion of the Hoc and Soc capsid proteins affects the surface and cellular uptake properties of bacteriophage T4 derived nanoparticles.

Authors:  Kelly Robertson; Yoko Furukawa; Alison Underwood; Lindsay Black; Jinny L Liu
Journal:  Biochem Biophys Res Commun       Date:  2012-01-21       Impact factor: 3.575

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  Modular interior loading and exterior decoration of a virus-like particle.

Authors:  Jhanvi Sharma; Masaki Uchida; Heini M Miettinen; Trevor Douglas
Journal:  Nanoscale       Date:  2017-07-27       Impact factor: 7.790

Review 4.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 5.  Nanoscale assemblies and their biomedical applications.

Authors:  Tais A P F Doll; Senthilkumar Raman; Raja Dey; Peter Burkhard
Journal:  J R Soc Interface       Date:  2013-01-09       Impact factor: 4.118

6.  A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.

Authors:  Simone Grasso; Chiara Lico; Francesca Imperatori; Luca Santi
Journal:  Transgenic Res       Date:  2012-10-30       Impact factor: 2.788

7.  CPMV-DOX delivers.

Authors:  Alaa A A Aljabali; Sourabh Shukla; George P Lomonossoff; Nicole F Steinmetz; David J Evans
Journal:  Mol Pharm       Date:  2012-08-06       Impact factor: 4.939

8.  Viral nanoparticle-encapsidated enzyme and restructured DNA for cell delivery and gene expression.

Authors:  Jinny L Liu; Aparna Banerjee Dixit; Kelly L Robertson; Eric Qiao; Lindsay W Black
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-26       Impact factor: 11.205

Review 9.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

Review 10.  Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

Authors:  Jaleh Varshosaz; Maryam Farzan
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.